» Articles » PMID: 26337907

G-CSF Is a Cancer Stem Cell-Specific Growth Factor-Response

Overview
Journal Cancer Res
Specialty Oncology
Date 2015 Sep 5
PMID 26337907
Citations 1
Authors
Affiliations
Soon will be listed here.
Citing Articles

Cancer Stem Cells and Neuroblastoma: Characteristics and Therapeutic Targeting Options.

Veschi V, Verona F, Thiele C Front Endocrinol (Lausanne). 2019; 10:782.

PMID: 31803140 PMC: 6877479. DOI: 10.3389/fendo.2019.00782.

References
1.
Ladenstein R, Valteau-Couanet D, Brock P, Yaniv I, Castel V, Laureys G . Randomized Trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1/SIOPEN study. J Clin Oncol. 2010; 28(21):3516-24. DOI: 10.1200/JCO.2009.27.3524. View

2.
Kowanetz M, Wu X, Lee J, Tan M, Hagenbeek T, Qu X . Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes. Proc Natl Acad Sci U S A. 2010; 107(50):21248-55. PMC: 3003076. DOI: 10.1073/pnas.1015855107. View

3.
Ara T, Nakata R, Sheard M, Shimada H, Buettner R, Groshen S . Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastoma. Cancer Res. 2013; 73(13):3852-64. PMC: 3740971. DOI: 10.1158/0008-5472.CAN-12-2353. View

4.
Hsu D, Agarwal S, Benham A, Coarfa C, Trahan D, Chen Z . G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic. Cancer Res. 2013; 73(13):4134-46. PMC: 4298227. DOI: 10.1158/0008-5472.CAN-12-4056. View

5.
Maris J, Healy J, Park J, Ladenstein R, Potschger U . G-CSF Is a Cancer Stem Cell-Specific Growth Factor-Letter. Cancer Res. 2015; 75(18):3991. DOI: 10.1158/0008-5472.CAN-15-1445. View